Schedule I (Tables)

12 Months Ended

Dec. 31, 2015

Maturities of commercial paper and long-term debt for the years ending December 31 are as follows:

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Balance Sheets



(in millions, except per share data)	December 31, 2015			December 31, 2014
Assets
Current assets:
Cash and cash equivalents	$	29		$	559
Short-term notes receivable from subsidiaries	—			27
Deferred income taxes and other current assets	313			271
Total current assets	342			857
Equity in net assets of subsidiaries	56,316			44,643
Long-term notes receivable from subsidiaries	9,679			4,635
Other assets	328			278
Total assets	$	66,665		$	50,413

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued liabilities	$	449		$	332
Note payable to subsidiary	310			215
Commercial paper and current maturities of long-term debt	6,587			1,365
Total current liabilities	7,346			1,912
Long-term debt, less current maturities	25,344			15,891
Deferred income taxes and other liabilities	145			156
Total liabilities	32,835			17,959
Commitments and contingencies (Note 5)
Stockholders’ equity:
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding	—			—
Common stock, $0.01 par value - 3,000 shares authorized; 953 and 954 issued and outstanding	10			10
Additional paid-in capital	29			—
Retained earnings	37,125			33,836
Accumulated other comprehensive loss	(3,334		)	(1,392		)
Total UnitedHealth Group stockholders’ equity	33,830			32,454
Total liabilities and stockholders’ equity	$	66,665		$	50,413

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Statements of Comprehensive Income



	For the Years Ended December 31,
(in millions)	2015			2014			2013
Revenues:
Investment and other income	$	396		$	293		$	252
Total revenues	396			293			252
Operating costs:
Operating costs	(17		)	1			(9		)
Interest expense	717			554			618
Total operating costs	700			555			609
Loss before income taxes	(304		)	(262		)	(357		)
Benefit for income taxes	111			96			130
Loss of parent company	(193		)	(166		)	(227		)
Equity in undistributed income of subsidiaries	6,006			5,785			5,852
Net earnings	5,813			5,619			5,625
Other comprehensive loss	(1,942		)	(484		)	(1,346		)
Comprehensive income	$	3,871		$	5,135		$	4,279

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Statements of Cash Flows



	For the Years Ended December 31,
(in millions)	2015			2014			2013
Operating activities
Cash flows from operating activities	$	1,727		$	7,445		$	5,099
Investing activities
Issuance of notes to subsidiaries	(5,064		)	(436		)	(1,517		)
Cash paid for acquisitions	(12,270		)	(1,852		)	(274		)
Return of capital to parent company	4,375			—			—
Capital contributions to subsidiaries	(1,109		)	(704		)	(942		)
Other, net	140			(9		)	275
Cash flows used for investing activities	(13,928		)	(3,001		)	(2,458		)
Financing activities
Common stock repurchases	(1,200		)	(4,008		)	(3,170		)
Proceeds from common stock issuances	402			462			598
Cash dividends paid	(1,786		)	(1,362		)	(1,056		)
Proceeds from (repayments of) commercial paper, net	3,666			(794		)	(474		)
Proceeds from issuance of long-term debt	11,982			1,997			2,235
Repayments of long-term debt	(1,041		)	(812		)	(943		)
Other, net	(352		)	(190		)	(34		)
Cash flows from (used for) financing activities	11,671			(4,707		)	(2,844		)
Decrease in cash and cash equivalents	(530		)	(263		)	(203		)
Cash and cash equivalents, beginning of period	559			822			1,025
Cash and cash equivalents, end of period	$	29		$	559		$	822

Supplemental cash flow disclosures
Cash paid for interest	$	573		$	578		$	618
Cash paid for income taxes	4,294			4,028			2,765

Maturities of commercial paper and long-term debt for the years ending December 31 are as follows: